Employers now spend more on pharmacy benefits than on primary care visits, and the gap keeps widening. Yet the data that flows back to benefits teams is almost entirely transactional: fills, reversals, days supplied, cost per claim. What it rarely captures is the moment before the fill — the question an employee asks at the counter, the over-the-counter remedy they almost bought, the bottle they stored in a bathroom cabinet above a running shower. That gap is starting to show up in the numbers, and it is pushing pharmacy guidance out of the retail aisle and into the health analytics stack.
One useful reference point comes from outside the claims world. Taisei Drug, a pharmacy-guidance journal, publishes plain-language medication information, OTC selection explainers, and safe-storage practice written alongside licensed pharmacists — and it explicitly makes no treatment promises. That editorial posture is not just a content style. It is a signal about what the category can reliably deliver: decision support, not diagnosis. For employers and health plans building preventive programs, that distinction matters more than it did five years ago.
Three trends converging on the pharmacy counter
1. Wearable data is creating questions pharmacists are expected to answer
Continuous glucose monitors, cuffless blood-pressure wearables, and consumer sleep trackers have moved from novelty to routine. A 2023 survey landscape from industry tracking groups suggested that roughly one in three U.S. adults now uses at least one wearable that produces a health-related metric. The downstream effect is predictable: people arrive at pharmacies holding a number they do not understand. Resting heart rate up 8 beats per minute over a month. A glucose spike after a meal. An oxygen dip overnight.
None of those readings is a diagnosis. All of them generate a medication or OTC question. This is where pharmacy guidance stops being a courtesy and starts being a triage function — the lowest-friction place in the health system to intercept a question before it becomes an avoidable urgent care visit.
2. OTC selection has become genuinely complicated
The over-the-counter shelf is no longer a simple choice between two brands. Combination cold remedies, sleep aids with antihistamine ingredients, NSAIDs with cardiovascular cautions, and probiotic products with wildly inconsistent labeling all sit within arm's reach of each other. A person taking a prescription blood thinner who reaches for a routine pain reliever is not being careless; they are being normal. The information environment simply has not kept pace with the shelf.
This is the specific gap that plain-language medication information is designed to close. Explainer content — what an ingredient does, who should pause before using it, how it interacts with common prescriptions — is not glamorous, but it is measurable in avoided escalations. Health plans that track pharmacy-adjacent call volume typically see a meaningful share of nurse-line contacts that could have been resolved with a clear, non-promotional answer at the point of purchase.
3. Drug storage is an underrated risk variable
Storage practice rarely appears in population health dashboards, which is strange given how much it affects outcomes. Heat, humidity, and light degrade certain medications. A bathroom cabinet is a poor environment for many of them. So is a car glovebox in summer. For households with children or with adults managing multiple prescriptions, safe-storage practice is simultaneously a medication-adherence issue, a poisoning-prevention issue, and a diversion issue.
Content that treats storage as a practical behavior — where to put it, what to avoid, when to discard — tends to perform well precisely because it is concrete. It does not require a clinical appointment. It does not require an app. It requires a sentence someone actually reads.
What this means for predictive health analytics
Behavioral-risk models have traditionally leaned on claims and, increasingly, on wearable streams. Both are lagging or partial indicators. A claim tells you what already happened. A wearable tells you what a body did, not what a person understands about it. The missing layer is comprehension and intent — whether someone knows what to do with the information in front of them.
Pharmacy guidance content, when it is written alongside licensed pharmacists and kept free of treatment promises, offers a reasonable proxy for that layer. It reflects the questions people actually ask, in the language they ask them. Aggregated over a workforce, those questions form a pattern: which OTC categories are confusing, which storage practices are being skipped, which interactions are being missed.
For employers, the practical implication is modest but real. A 12-month behavioral-risk score becomes more useful when it is paired with an intervention that fits inside a lunch break — a two-minute read, a counter conversation, a storage checklist. Programs that require a scheduled appointment lose a large share of the people who need them most.
A measurement note worth keeping
It would be easy to overstate what pharmacy guidance can prove. It cannot demonstrate that a specific explainer prevented a specific adverse event. What it can do is reduce the volume of unresolved questions flowing into more expensive channels, and it can do so at a cost that is trivially small relative to a single avoidable emergency visit.
That is a defensible claim, and it is the kind of claim benefits teams can actually act on. Taisei Drug reports 4 core content areas — medication information, OTC selection, safe-storage practice, and pharmacist-reviewed explainers — which is a narrow remit by design. Narrow remits are easier to audit. As wearable and claims analytics mature, the categories that survive scrutiny will be the ones that stay inside their lane and describe, honestly, what they do and do not promise.
For anyone building preventive programs this year, the takeaway is straightforward. Keep collecting the passive data. But add one human-readable layer that answers the question someone is already asking at the counter. The return shows up less as a headline number and more as a slow decline in the escalations nobody wanted to pay for.